Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q3 2025 (September 30)14holders +2
4new positions
2sold out
$2.17avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, up 2 from Q2 2025. 4 opened new positions and 2 sold out. The largest holders were Gagnon Securities LLC ($39K), Federation des caisses Desjardins du Quebec ($7K) and Rhumbline Advisers ($4K).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $39K |
| Exits | 2 | $413 |
All 13F filers, Q2 2025 → Q3 2025: 17,896 shares bought and 13,855 shares sold, net +4,041 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Gagnon Securities LLC | 0.01% | New | 17,822 | $39K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,388 | $7K |
| Rhumbline Advisers | 0.00% | No change | 1,768 | $4K |
| Bank of America Corp. | 0.00% | No change | 303 | $658 |
| GAMMA Investing LLC | 0.00% | Reduce -93.5% | 135 | $293 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -97.2% | 57 | $124 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 38 | $82 |
| UBS Group AG | 0.00% | Reduce -99.7% | 23 | $50 |
| Your Advocates Ltd., LLP | 0.00% | New | 19 | $41 |
| Rothschild Investment LLC | 0.00% | New | 17 | $37 |
| Group One Trading LLC | 0.00% | No change | 11 | $24 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 2 | $4 |
| Morgan Stanley | 0.00% | Reduce -99.9% | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -75.0% | 1 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.